Business, energy, technology, markets and global industry news from Business News Today

degenerative disc disease

PharmaDeviceNews degenerative disc disease
FibroBiologics is expanding its intellectual property strategy for degenerative disc disease with an Australian patent acceptance covering cannabidiol as an adjuvant to fibroblast-based regenerative therapy, although clinical validation remains the critical next step. Representative image.
Pharma & Biotech

What FibroBiologics’ Australian cannabidiol patent means for its degenerative disc disease pipeline

FibroBiologics expands its disc disease IP in Australia, but clinical validation and funding remain the bigger tests for its regenerative strategy.

Read More
SurGenTec ION-L enters lumbar spine market as surgeons weigh minimally invasive fusion promise
Medical Devices & Diagnostics

Can SurGenTec’s ION-L system change how lumbar facet fixation fits into spine surgery?

Find out how SurGenTec’s ION-L FDA clearance could reshape minimally invasive lumbar facet fixation and spine surgery adoption.

Read More
Xenix Medical’s expandable lumbar fusion push now faces the real commercial trial
Medical Devices & Diagnostics

Xenix Medical’s Lux system targets a key pain point in lumbar fusion surgery

Lux gives Xenix Medical a lumbar fusion opening. Read why adoption, evidence and surgeon workflow now matter most.

Read More